Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
International Journal of Cancer
|
August 19, 1993
Human melanoma cells express a functional interleukin-2 receptor
S Plaisance, E Rubinstein, A Alileche, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 20, 1998
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
D Valmori, J F Fonteneau, C M Lizana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group
U Keilholz, M Willhauck, D Rimoldi, et al.
The Journal of Experimental Medicine
|
September 28, 1999
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
D E Speiser, M J Pittet, D Valmori, et al.
The Journal of Experimental Medicine
|
November 6, 1998
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
P Romero, P R Dunbar, D Valmori, et al.
International Journal of Cancer
|
August 14, 1999
cDNA and protein characterization of human MAGE-10
D Rimoldi, S Salvi, D Reed, et al.
Science (New York, N.Y.)
|
November 22, 1996
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape
M Hahne, D Rimoldi, M Schröter, et al.
The Journal of Experimental Medicine
|
December 6, 2000
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
F Berard, P Blanco, J Davoust, et al.
Cancer Research
|
September 2, 2000
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients
D Valmori, V Dutoit, D Liénard, et al.
International Immunology
|
December 11, 1999
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues
D Valmori, J F Fonteneau, S Valitutti, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
International Journal of Cancer
|
August 19, 1993
Human melanoma cells express a functional interleukin-2 receptor
S Plaisance, E Rubinstein, A Alileche, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 20, 1998
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
D Valmori, J F Fonteneau, C M Lizana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group
U Keilholz, M Willhauck, D Rimoldi, et al.
The Journal of Experimental Medicine
|
September 28, 1999
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
D E Speiser, M J Pittet, D Valmori, et al.
The Journal of Experimental Medicine
|
November 6, 1998
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
P Romero, P R Dunbar, D Valmori, et al.
International Journal of Cancer
|
August 14, 1999
cDNA and protein characterization of human MAGE-10
D Rimoldi, S Salvi, D Reed, et al.
Science (New York, N.Y.)
|
November 22, 1996
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape
M Hahne, D Rimoldi, M Schröter, et al.
The Journal of Experimental Medicine
|
December 6, 2000
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
F Berard, P Blanco, J Davoust, et al.
Cancer Research
|
September 2, 2000
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients
D Valmori, V Dutoit, D Liénard, et al.
International Immunology
|
December 11, 1999
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues
D Valmori, J F Fonteneau, S Valitutti, et al.
Page
of 7